Hoffmann-La Roche: all 2,744 studies
Page 14 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.CompletedNCT00087594Phase 4Results posted
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + RibavirinCompletedNCT00087568Phase 4Results posted
- A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple SclerosisCompletedNCT00087529Phase 2/3Results posted
- A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With BonvivaCompletedNCT00081653Phase 4Results posted
- Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary FibrosisCompletedNCT00080223Phase 2Results posted
- A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00077857Phase 2Results posted
- A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.CompletedNCT00077766Phase 3Results posted
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).CompletedNCT00077649Phase 4Results posted
- ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.CompletedNCT00077636Phase 4Results posted
- A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.CompletedNCT00077623Phase 3Results posted
- A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNCT00077610Phase 3Results posted
- A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon CancerCompletedNCT00069121Phase 3Results posted
- A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal CancerCompletedNCT00069108Phase 3Results posted
- A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal CancerCompletedNCT00069095Phase 3Results posted
- Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior ChemotherapyCompletedNCT00063154Phase 2Results posted
- A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian CancerCompletedNCT00058552Phase 2Results posted
- Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate CancerCompletedNCT00058539Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac TransplantationCompletedNCT00048165Phase 4Results posted
- DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal OsteoporosisCompletedNCT00048074Phase 3Results posted
- MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal OsteoporosisCompletedNCT00048061Phase 3Results posted
- A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.CompletedNCT00048048Phase 2Results posted
- A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal AnemiaCompletedNCT00048035Phase 2Results posted
- Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast CancerCompletedNCT00045032Phase 3Results posted
- Safety Study of rhuMAb 2C4 to Treat Advanced Solid TumorsCompletedNCT00027027Phase 1Results posted
- T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and AdolescentsCompletedNCT00022763Phase 2Results posted
- Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal CancerCompletedNCT00022698Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast CancerCompletedNCT00022672Phase 3Results posted
- A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon CancerCompletedNCT00009737Phase 3Results posted
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple SclerosisActive, not recruitingNCT07667322Phase 1
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese ParticipantsActive, not recruitingNCT07626515Phase 1
- A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or OverweightActive, not recruitingNCT07499050Phase 1
- A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart DiseaseTerminatedNCT07495813Phase 1
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple SclerosisActive, not recruitingNCT07483450Phase 4
- A Clinical Study to Evaluate the Effects of RO7875913 in Healthy Participants and of RO7875913 With Cevostamab in Participants With Relapsed/Refractory Multiple MyelomaActive, not recruitingNCT07342114Phase 1
- A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy ParticipantsCompletedNCT07329972Phase 1
- A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal CancerWithdrawnNCT07323576Phase 2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's DiseaseActive, not recruitingNCT07246941Phase 1
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)Active, not recruitingNCT07234942Phase 1
- A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisActive, not recruitingNCT07223697Phase 2
- A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male ParticipantsCompletedNCT07214766Phase 1
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast CancerTerminatedNCT07214662Phase 1
- A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)WithdrawnNCT07172022Phase 2
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseActive, not recruitingNCT07170150Phase 3
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseActive, not recruitingNCT07169578Phase 3
- A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of InavolisibCompletedNCT07144111Phase 1
- A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or ObesityActive, not recruitingNCT07137585Phase 1
- A Study Evaluating the Effect of Daily Oral Tifeglipron (RO7795081) in Participants With Obesity or Overweight With at Least One Weight-Related ComorbidityCompletedNCT07081958Phase 2
- A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)Active, not recruitingNCT07074886Phase 2
- A COPD Data Registry for Participants With Frequent ExacerbationsWithdrawnNCT07059273
- A Study to Evaluate the Relative Bioavailability of Two Tablet Formulations Compared to Capsule Formulation and the Effect of Food and Proton Pump Inhibitor on ZN-A-1041 Tablet(s) in Healthy ParticipantsCompletedNCT07051993Phase 1
- A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory TreatmentCompletedNCT07025811Phase 4
- A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection ConditionsCompletedNCT07025577Phase 1
- A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple SclerosisActive, not recruitingNCT07008378Phase 1
- A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)WithdrawnNCT06984341Phase 1
- A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult ParticipantsActive, not recruitingNCT06982131Phase 1
- Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida VaginitisCompletedNCT06975436
- A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related ComorbidityActive, not recruitingNCT06965413Phase 2
- A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)TerminatedNCT06961370Phase 1
- A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT06934044Phase 1
- A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver FibrosisActive, not recruitingNCT06903065Phase 1
- An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care TreatmentActive, not recruitingNCT06883240
- 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With SchizophreniaCompletedNCT06880328Phase 1
- A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic DermatitisActive, not recruitingNCT06863961Phase 2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular EdemaCompletedNCT06850922Phase 1/2
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)Active, not recruitingNCT06847854Phase 1
- A Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Divarasib in Healthy ParticipantsCompletedNCT06835465Phase 1
- A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC)WithdrawnNCT06816017Phase 1
- A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081CompletedNCT06809608Phase 1
- A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular DegenerationActive, not recruitingNCT06795048Phase 4
- A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular EdemaCompletedNCT06771271Phase 1
- A Study to Evaluate the Pharmacokinetics of Divarasib in Healthy Participants and Participants With Impaired Hepatic FunctionCompletedNCT06734208Phase 1
- A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary SyndromeCompletedNCT06734117
- A Study Investigating [14C]-Labeled RO7269162 in Healthy Male ParticipantsCompletedNCT06733298Phase 1
- A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)CompletedNCT06723288
- A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative ColitisCompletedNCT06693908Phase 1
- A Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Divarasib in Healthy ParticipantsCompletedNCT06690138Phase 1
- A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)Active, not recruitingNCT06680817
- A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy ParticipantsCompletedNCT06677957Phase 1
- Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion CarriersCompletedNCT06667414
- A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes MellitusCompletedNCT06628362Phase 2
- A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaActive, not recruitingNCT06624085Phase 1
- A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT06624059Phase 3
- A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive DiseaseTerminatedNCT06603246Phase 1
- A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)TerminatedNCT06602453Phase 2
- A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06589986Phase 3
- A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06588855Phase 3
- A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid TumorsActive, not recruitingNCT06537310Phase 1
- A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)Active, not recruitingNCT06534983Phase 2
- A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related ComorbidityCompletedNCT06525935Phase 2
- A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment PeriodActive, not recruitingNCT06524375Phase 2
- A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial ChemoembolizationCompletedNCT06503250
- A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung CancerActive, not recruitingNCT06497556Phase 3
- A Study Evaluating Single-agent Inavolisib, Inavolisib Plus Atezolizumab in PIK3CA-Mutated CancersActive, not recruitingNCT06496568Phase 1
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid TumorsTerminatedNCT06488716Phase 1
- A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy SubjectsCompletedNCT06462118Phase 1
- A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)Active, not recruitingNCT06450639Phase 2
- Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)Active, not recruitingNCT06439576
- A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)Active, not recruitingNCT06402838Phase 2
- A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid TumorsWithdrawnNCT06372574Phase 1
- A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors with Resectable Disease with Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)WithdrawnNCT06331598Phase 2